Next Article in Journal
Nogier Reflex: Physiological and Experimental Results in Auricular Medicine–A New Hypothesis
Previous Article in Journal
Kampo (Traditional Japanese Herbal) Formulae for Treatment of Stomatitis and Oral Mucositis
Previous Article in Special Issue
The Expanding Role of Radiosurgery for Brain Metastases
Article Menu
Issue 4 (December) cover image

Export Article

Open AccessReview

Assessing the Role of Artificial Intelligence (AI) in Clinical Oncology: Utility of Machine Learning in Radiotherapy Target Volume Delineation

1
Department of Clinical Oncology, Leeds Cancer Centre, St James’s Institute of Oncology, Leeds Teaching Hospitals NHS Trust, Leeds LS9 7TF, UK
2
Department of Radiology, Worcestershire Acute Hospitals NHS Trust, Worcester WR5 1DD, UK
3
Worcestershire Oncology Centre, Worcestershire Acute Hospitals NHS Trust, Worcester WR5 1DD, UK
*
Author to whom correspondence should be addressed.
Medicines 2018, 5(4), 131; https://doi.org/10.3390/medicines5040131
Received: 30 November 2018 / Revised: 4 December 2018 / Accepted: 7 December 2018 / Published: 11 December 2018
(This article belongs to the Special Issue Advances and Perspectives in Radiotherapy Treatments)
  |  
PDF [368 KB, uploaded 11 December 2018]
  |  

Abstract

The fields of radiotherapy and clinical oncology have been rapidly changed by the advances of technology. Improvement in computer processing power and imaging quality heralded precision radiotherapy allowing radiotherapy to be delivered efficiently, safely and effectively for patient benefit. Artificial intelligence (AI) is an emerging field of computer science which uses computer models and algorithms to replicate human-like intelligence and perform specific tasks which offers a huge potential to healthcare. We reviewed and presented the history, evolution and advancement in the fields of radiotherapy, clinical oncology and machine learning. Radiotherapy target delineation is a complex task of outlining tumour and organ at risks volumes to allow accurate delivery of radiotherapy. We discussed the radiotherapy planning, treatment delivery and reviewed how technology can help with this challenging process. We explored the evidence and clinical application of machine learning to radiotherapy. We concluded on the challenges, possible future directions and potential collaborations to achieve better outcome for cancer patients. View Full-Text
Keywords: artificial intelligence (AI); clinical oncology; deep learning; image guided radiotherapy (IGRT); intensity modulated radiotherapy (IMRT); machine learning; radiotherapy; stereotactic ablative radiotherapy (SABR); target volume delineation; volumetric modulated arc therapy (VMAT) artificial intelligence (AI); clinical oncology; deep learning; image guided radiotherapy (IGRT); intensity modulated radiotherapy (IMRT); machine learning; radiotherapy; stereotactic ablative radiotherapy (SABR); target volume delineation; volumetric modulated arc therapy (VMAT)
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Boon, I.S.; Au Yong, T.P.T.; Boon, C.S. Assessing the Role of Artificial Intelligence (AI) in Clinical Oncology: Utility of Machine Learning in Radiotherapy Target Volume Delineation. Medicines 2018, 5, 131.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Medicines EISSN 2305-6320 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top